Ironwood Pharmaceuticals, Inc. reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported revenue was USD 107.2 million compared to USD 117.13 million a year ago. Net income was USD 48.87 million compared to USD 41.37 million a year ago. Basic earnings per share from continuing operations was USD 0.32 compared to USD 0.25 a year ago. Diluted earnings per share from continuing operations was USD 0.27 compared to USD 0.25 a year ago.
For the full year, revenue was USD 410.6 million compared to USD 413.75 million a year ago. Net income was USD 175.07 million compared to USD 528.45 million a year ago. Basic earnings per share from continuing operations was USD 1.13 compared to USD 3.26 a year ago. Diluted earnings per share from continuing operations was USD 0.96 compared to USD 3.21 a year ago.